Literature DB >> 9128300

Management of Crohn's disease in adults.

S B Hanauer1, S Meyers.   

Abstract

Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data are not available that will withstand objective scrutiny, a recommendation may be made based on a consensus of experts. Guidelines are intended to apply to the clinical situation for all physicians without regard to specialty. Guidelines are intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. Given the wide range of choices in any health care problem, the physician should select the course best suited to the individual patient and the clinical situation presented. These guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee. Expert opinion is solicited from the outset for the document. Guidelines are reviewed in depth by the Committee, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.

Entities:  

Mesh:

Year:  1997        PMID: 9128300

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

Review 1.  Management of Crohn's disease.

Authors:  D S Rampton
Journal:  BMJ       Date:  1999-12-04

Review 2.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  New treatments for inflammatory bowel disease.

Authors:  David S Rampton; D Phil
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

4.  Management of difficult inflammatory bowel disease: where are we now?

Authors:  DS Rampton
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 5.  Infliximab treatment for Crohn's disease.

Authors:  C A Conroy; R Cattell
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

Review 6.  Evolutionary biologic therapy for inflammatory bowel disease.

Authors:  S B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  1999-12

7.  Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes.

Authors:  Marla C. Dubinsky; Phillip P. Fleshner
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

8.  Herpes simplex virus colitis in a patient with Crohn's disease and hepatitis B and d cirrhosis.

Authors:  Jenny O Smith; Richard K Sterling; A Scott Mills; R Todd Stravitz; Velimir A C Luketic; Michael Fuchs; Arun J Sanyal; Mitchell L Shiffman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

Review 9.  Practical guidelines for the treatment of inflammatory bowel disease.

Authors:  T Kuhbacher; U R Fölsch
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

10.  Current use of immunosuppressive agents in inflammatory bowel disease patients in East China.

Authors:  Li-Juan Huang; Qin Zhu; Min Lei; Qian Cao
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.